AgeX Therapeutics, Inc.·4

Jun 8, 6:24 PM ET

MALIK NAFEES NASEER 4

4 · AgeX Therapeutics, Inc. · Filed Jun 8, 2021

Insider Transaction Report

Form 4
Period: 2021-06-04
MALIK NAFEES NASEER
Chief Operating Officer
Transactions
  • Award

    Option to Purchase Common Stock

    2021-06-04+75,00075,000 total
    Exercise: $1.45Exp: 2031-06-03Common Stock (75,000 underlying)
Footnotes (1)
  • [F1]Twenty-five percent of the options will vest and thereby become exercisable upon completion of one year of service from the date of grant, and the balance of the options will vest in 36 equal monthly installments commencing on the first anniversary of the date of grant, subject to his continued service as an officer on the applicable vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION